Andesa Financial Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$218K Buy
11,613
+4,887
+73% +$211K 0.11% 118
2022
Q4
$345K Sell
6,726
-4,984
-43% -$239K 0.19% 103
2022
Q3
$516K Buy
11,710
+5,606
+92% +$272K 0.18% 86
2022
Q2
$320K Buy
6,104
+83
+1% +$4.23K 0.2% 96
2022
Q1
$312K Buy
6,021
+1,705
+40% +$88.5K 0.17% 111
2021
Q4
$255K Buy
+4,316
New +$214K 0.13% 135
2021
Q1
Sell
-6,633
Closed -$243K 147
2020
Q4
$243K Sell
6,633
-7,561
-53% -$277K 0.16% 102
2020
Q3
$494K Sell
14,194
-1,360
-9% -$47.7K 0.2% 87
2020
Q2
$481K Sell
15,554
-43,225
-74% -$1.47M 0.43% 62
2020
Q1
$1.82M Sell
58,779
-8,979
-13% -$306K 2.04% 16
2019
Q4
$2.51M Buy
67,758
+951
+1% +$33.9K 2.19% 17
2019
Q3
$2.28M Buy
66,807
+2,844
+4% +$103K 2.2% 17
2019
Q2
$2.62M Sell
63,963
-57,673
-47% -$2.29M 2.49% 14
2019
Q1
$4.9M Buy
121,636
+63,680
+110% +$2.55M 2.42% 13
2018
Q4
$2.4M Buy
57,956
+34,125
+143% +$1.42M 2.85% 6
2018
Q3
$996K Buy
23,831
+1,027
+5% +$39.5K 1.53% 26
2018
Q2
$785K Buy
22,804
+1,292
+6% +$44.2K 1.27% 33
2018
Q1
$722K Sell
21,512
-738
-3% -$25.4K 1.19% 34
2017
Q4
$763K Buy
+22,250
New +$759K 1.13% 38

Other funds holding PFE

Andesa Financial Management's PFE Position: Q1 2023 in Review

Andesa Financial Management increased its Pfizer (PFE) stake by 73% in Q1 2023, buying an estimated $211K and bringing the position to 11,613 shares worth $218K. The position accounts for 0.11% of the portfolio, ranked #118.

Andesa Financial Management first reported a position in PFE in Q4 2017 and has held it in 19 quarters since. The position peaked at $4.9M in Q1 2019. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Andesa Financial Management held 11,613 shares of Pfizer worth $218K as of Q1 2023.
  • Andesa Financial Management bought 4,887 Pfizer shares in Q1 2023, an estimated $211K.
  • Pfizer made up 0.11% of Andesa Financial Management's portfolio in Q1 2023, its #118 holding.
  • Andesa Financial Management first reported a position in Pfizer in Q4 2017 and has held it in 19 quarters since.
  • Andesa Financial Management's Pfizer position peaked at $4.9M in Q1 2019.
  • 3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Andesa Financial Management's 13F filing for Q1 2023, filed 5 May 2023.